Skip to content

Clinical trials

Hemorrhagic Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Disorders Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20082
20102
20111
20122
20132
20146
20151
20162
20176
20187
20195
20203
20211
20223
20235
20245
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Recruiting9
Unknown status5
Terminated5
Withdrawn4
Active, not recruiting4
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical8
Swedish Orphan Biovitrum6
Spark Therapeutics, Inc.3
Baxalta now part of Shire2
Genzyme, a Sanofi Company2
Kedrion S.p.A.2
Novartis Pharmaceuticals2
Seagen Inc.2
Takeda2
University Hospital, Strasbourg, France2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhagic Disorders63
Hematologic Diseases43
Blood Coagulation Disorders34
Coagulation Protein Disorders23
Hemophilia A22
Genetic Diseases, Inborn21
Hemostatic Disorders18
Blood Coagulation Disorders, Inherited16
Immune System Diseases11
Immunoproliferative Disorders10

Trials

Showing 51 to 63 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.